Web10. feb 2024 · TOPAZ-1 enrolled 685 patients from around the world who had received no prior treatment for unresectable, locally advanced, recurrent, or metastatic biliary tract … WebAdvanced BTC is a rare, heterogenous cancer with poor prognosis. At the preplanned interim analysis (data cutoff 11 August 2024) of TOPAZ-1 (NCT03875235), D + GC significantly improved OS versus PBO + GC in pts with advanced BTC (hazard ratio [HR], 0.80; 95% confidence interval [CI], 0.66–0.97; p=0.021).
A Phase 2 Multi-institutional Study of Nivolumab for Patients With ...
WebASCO’s Targeted Agent and Profiling Utilization Registry (TAPUR) Study is a non-randomized clinical trial aiming to describe the performance of commercially available, targeted … Web18. jan 2024 · TOPAZ-1 is the first phase 3 trial to demonstrate the benefit of immunotherapy for improved overall survival, in combination with chemotherapy, creating … dassault seclin recrutement
ESMO Congress OncologyPRO
Web20. jan 2024 · TOPaZ is a randomised open-label clinical trial for people with Osteogenesis Imperfecta (OI). The study aims to investigate whether a two-year spell of treatment with a drug called Teriparatide (TPTD) followed by treatment with another drug called Zoledronic acid (ZA) reduces the risk of broken bones occurring in people with Osteogenesis … Web52MO - A randomized phase II trial of durvalumab and tremelIMUmab with gemcitabine or gemcitabine and cisplatin compared to gemcitabine and cisplatin in treatment-naïve patients with CHolangio- and gallbladdEr Carcinoma (IMMUCHEC) Date 10 Sep 2024 Session Mini Oral session: GI, upper digestive Topics Tumour Site Hepatobiliary Cancers Presenters Web14. mar 2024 · Detailed Description: A Phase III Randomized, Double-Blind Placebo Controlled, Multi-Regional, International Study of Durvalumab in Combination with … maropitant posologia